Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-11

Clinical Trial Update: A Novel TBI Free Conditioning Protocol for Haploidentical Transplant in Acquired Aplastic Anemia: [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a novel TBI-free conditioning protocol for haploidentical transplant in acquired aplastic anemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Blood and Marrow Transplant (NIBMT), Pakistan | Conditions: Aplastic Anemia Idiopathic | Phase 2 | Status: UNKNOWN